The NCI designation is important for you.
NCI comprehensive cancer center designation recognizes that Holden provides Iowans with access to a range of cancer treatment opportunities that few other U.S. cancer centers can offer, including a vast array of clinical trials of some of the newest therapies.
We can offer comprehensive treatment for your cancer.
An emerging body of evidence suggests that treatment at a comprehensive cancer center may offer patients better chances for long-term survival.
The designation recognizes Holden’s ability to conduct cutting-edge scientific research and convert those laboratory findings into innovative therapies for patients in the real world.
The comprehensive designation means Holden’s care is for cancer across the spectrum, from the most common to the rarest types of cancer.
We are a resource for Iowa and the nation.
Scientists, physicians, nurses, and other professionals working at Holden team up with experts at other NCI-designated cancer centers to develop new advances in cancer care.
Over the past five years, Holden received more than $70 million in total funding from the NCI to support cutting-edge research. When combined with private donations and other grants, that level of support helps to draw the world’s best cancer researchers and physicians to our center.
Holden trains future cancer physicians and scientists who work side by side with our faculty in both research and patient care.
